Uteron Pharma Operations, based in Liege (Belgium) is a wholly owned subsidiary of Uteron Pharma, a research company dedicated to the development of innovative, controlled release devices that serve as a delivery platform for known active pharmaceutical ingredients.

Together with its founding stakeholders (the University of Liege, the Walloon Region, and Mithra pharmaceuticals) Uteron has developed a hormonal intra-uterine device (IUD). Extensive clinical trials to prove contraception are currently being conducted in cooperation with its US based development partner Medicines360.

Read More ...